Winston Pharmaceuticals, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 03/31/10 Q1

ended 12/31/09 FY 2009

ended 09/30/09 Q3

ended 06/30/09 Q2

ended 03/31/09 Q1

Prospectuses and Registrations Filter

Securities registration termination

Notice of sale of securities

Prospectus supplement

Registration of securities – amended

Registration of securities

Ownership Filter

Penneys Neal Stuart

Pharmaceutical Financial Syndicate, LLC

Pharmaceutical Financial Syndicate, LLC

Bernstein Joel E.

Uppaluri Subbarao V

News Filter

Material Definitive Agreement, Change in Directors, Officers or Compensation, Other Events, Financial Statements or Exhibits

Change in Directors, Officers or Compensation, Other Events, Financial Statements or Exhibits

Laboratories, Inc. Receives Notice of Non-Compliance in Canada for Its New Drug Submission of CIVANEX to Treat Osteoarthritis

Announces Election of New Chief Executive Officer and Chairman of the Board of Directors

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Preliminary info

Preliminary info

Other Filter

Scanned paper annual report submission

Confidential treatment order

Statement regarding change in majority of directors

Letter from the SEC

Correspondence with the SEC